Index
Grant: UC Davis — COVID-19 Antiviral Studies (Lark L. Coffey) (Coefficient Giving → University of California, Davis)
Verdictconfirmed95%
1 check · 4/9/2026Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Our claim
entire record- Name
- UC Davis — COVID-19 Antiviral Studies (Lark L. Coffey)
- Amount
- $100,642
- Currency
- USD
- Date
- March 2021
- Notes
[Scientific Research] Grant Investigators: Heather Youngs and Chris Somerville This page was reviewed but not written by the grant investigators. UC Davis staff also reviewed this page prior to publication. Open Philanthropy recommended a grant of $100,642 to UC Davis to enab… expand
[Scientific Research] Grant Investigators: Heather Youngs and Chris Somerville This page was reviewed but not written by the grant investigators. UC Davis staff also reviewed this page prior to publication. Open Philanthropy recommended a grant of $100,642 to UC Davis to enable Associate Professor Lark L. Coffey to collaborate with researchers at Duke University and the Weill Cornell Medical College of Cornell University to study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus. This follows our May 2020 support for earlier phases of the study at Duke University and falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.
Source evidence
1 src · 1 checkconfirmed95%deterministic-row-match · 4/9/2026
- Name
- UC Davis — COVID-19 Antiviral Studies (Lark L. Coffey)
- Grantee
- University of California, Davis
- Focus Area
- Scientific Research
- Amount
- $100,642.00
- Date
- March 2021
NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Case № gKrw8-UeM5Filed 4/9/2026Confidence 95%